Showing results (41-50 of 253) with videos related to

Sort By:
Pageof 26
Southern African Journal of HIV Medicine|May 19, 2021
Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluidEric H Decloedt, Phumla Z Sinxadi, Lubbe Wiesner, et al.
Southern African Journal of Infectious Diseases|October 2, 2023
Severe efavirenz associated neurotoxicity: A retrospective cohort studyPriyadarshini Arnab, Roland Croxford, Janet Scott, et al.
Neurology. Clinical Practice|March 20, 2020
The neurologic phenotype of South African patients with HIV-associated neurocognitive impairmentSean G Anderson, Michael McCaul, Saye Khoo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 19, 2024
Pharmacokinetics of Single-Dose Versus Double-Dose Dolutegravir After Switching From a Failing Efavirenz-Based RegimenRulan Griesel, Clifford G Banda, Ying Zhao, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Discovery of Novel Cyclic Ethers with Synergistic Antiplasmodial Activity in Combination with ValinomycinDaniel J Watson, Paul R Meyers, Kojo Sekyi Acquah, et al.
The Journal of Antimicrobial Chemotherapy|May 14, 2019
Pharmacokinetics of adjusted-dose 8-hourly lopinavir/ritonavir in HIV-infected children co-treated with rifampicinHelena Rabie, Holly Rawizza, Peter Zuidewind, et al.
International Journal of Public Health|September 7, 2023
The Association Between Urinary Concentrations of Organophosphate Metabolites and Asthma-Related Outcomes Among Schoolchildren From Informal SettlementsMashudu Mthethwa, Mohamed Jeebhay, Toyib Olaniyan, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2014
Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavirHarry Moultrie, Helen McIlleron, Shobna Sawry, et al.
Dalton Transactions (Cambridge, England : 2003)|February 26, 2016
Cyclopalladated organosilane-tethered thiosemicarbazones: novel strategies for improving antiplasmodial activityMuneebah Adams, Linley Barnard, Carmen de Kock, et al.
BMC Pharmacology & Toxicology|November 20, 2014
Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapySuhashni Naiker, Cathy Connolly, Lubbe Wiesner, et al.
Pageof 26